Work

Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study

Year: 2011

Type: article

Source: European Journal of Heart Failure

DOI: 10.1093/eurjhf/hfr034

Authors: Bertram Pitt, Roberto Latini, Aldo P. Maggioni, Scott D. Solomon, Beverly A. Smith, Melanie Wright, Margaret F. Prescott, John J.V. McMurray

Institutions: University of Michigan, Mario Negri Institute for Pharmacological Research, Associazione Nazionale Medici Cardiologi Ospedalieri, Brigham and Women's Hospital, Novartis (Switzerland), Novartis (United States), British Heart Foundation, University of Glasgow

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W1994288384

FWCI: 2.851

Cites: 21

Cited by: 24

Related to: 10